Detalhe da pesquisa
1.
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach.
BMC Pulm Med
; 23(1): 292, 2023 Aug 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37559024
2.
Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia.
EBioMedicine
; 93: 104667, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37336058
3.
Relationships Between Age, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), and Mortality Among Critically Ill Adults: A Cohort Study.
Shock
; 57(2): 205-211, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34812186
4.
Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical Illness.
Crit Care Explor
; 4(9): e0754, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-36050993
5.
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19.
Crit Care Explor
; 4(12): e0813, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36567786
6.
TLRs in COVID-19: How they drive immunopathology and the rationale for modulation.
Innate Immun
; 27(7-8): 503-513, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34806446
7.
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019.
Crit Care Explor
; 3(12): e0591, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34909698